CRNX icon

Crinetics Pharmaceuticals
CRNX

Overview Fund Activity

234 hedge funds and large institutions have $3.69B invested in Crinetics Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 103 increasing their positions, 57 reducing their positions, and 16 closing their positions.

Holders
234
Holders Change
+31
Holders Change %
+15.27%
% of All Funds
3.4%
Holding in Top 10
13
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.19%
New
48
Increased
103
Reduced
57
Closed
16
Calls
$13.5M
Puts
$8.82M
Net Calls
+$4.67M
Net Calls Change
-$1.37M

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$207M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$202M
3
DCM
3
Driehaus Capital Management
Illinois
$274M
4
BlackRock
4
BlackRock
New York
$279M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$197M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$125M
2
T. Rowe Price Investment Management
2
T. Rowe Price Investment Management
Maryland
$60.3M
3
PBA
3
Paradigm Biocapital Advisors
New York
$113M
4
FLAM
4
First Light Asset Management
Minnesota
$53.8M
5
State Street
5
State Street
Massachusetts
$126M
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$279M 6,230,371 +794,267 +15%
DCM
2
Driehaus Capital Management
Illinois
$274M 6,112,173 +885,876 +17%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$207M 4,620,413 +1,648,831 +55%
Vanguard Group
4
Vanguard Group
Pennsylvania
$202M 4,514,478 +939,402 +26%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$197M 4,406,456 +583,238 +15%
EC
6
EcoR1 Capital
California
$186M 4,155,375 – –
Fidelity Investments
7
Fidelity Investments
Massachusetts
$183M 4,096,795 -366,881 -8%
State Street
8
State Street
Massachusetts
$126M 2,812,923 -442,330 -14%
Point72 Asset Management
9
Point72 Asset Management
Connecticut
$125M 2,780,856 -2,168,630 -44%
Jennison Associates
10
Jennison Associates
New York
$125M 2,780,144 -37,710 -1%
PBA
11
Paradigm Biocapital Advisors
New York
$113M 2,513,302 -611,447 -20%
Janus Henderson Group
12
Janus Henderson Group
United Kingdom
$110M 2,455,661 +477,489 +24%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$75.2M 1,678,387 +276,984 +20%
PA
14
Perceptive Advisors
New York
$66.1M 1,476,203 – –
CAM
15
Cormorant Asset Management
Massachusetts
$60.5M 1,350,000 +200,000 +17%
T. Rowe Price Investment Management
16
T. Rowe Price Investment Management
Maryland
$60.3M 1,347,210 -1,307,519 -49%
O
17
OrbiMed
New York
$57.4M 1,280,800 -104,200 -8%
FLAM
18
First Light Asset Management
Minnesota
$53.8M 1,200,508 -489,669 -29%
AG
19
Artal Group
Luxembourg
$47.7M 1,066,064 -324,413 -23%
NHAS
20
Novo Holdings A/S
Denmark
$44.8M 1,000,000 -98,600 -9%
Lord, Abbett & Co
21
Lord, Abbett & Co
New Jersey
$39.8M 887,921 -76,647 -8%
Franklin Resources
22
Franklin Resources
California
$38.6M 861,422 +448,213 +108%
Morgan Stanley
23
Morgan Stanley
New York
$37.6M 838,625 +226,425 +37%
EAM
24
Eventide Asset Management
Massachusetts
$32.9M 735,088 -324,545 -31%
SSA
25
Schonfeld Strategic Advisors
New York
$29.3M 653,557 +518,264 +383%
1
2 3 4 5